Literature DB >> 26022173

Spinal muscular atrophies.

Basil T Darras1.   

Abstract

Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is caused by decreased levels of the survival of motor neuron (SMN) protein and is the most common genetic cause of infant mortality. Its inheritance pattern is autosomal recessive, resulting from mutations involving the SMN1 gene on chromosome 5q13. Unlike other autosomal recessive diseases, the SMN gene has a unique structure (an inverted duplication) that presents potential therapeutic targets. Although there is currently no effective treatment of SMA, the field of translational research in this disorder is active and clinical trials are ongoing. Advances in the multidisciplinary supportive care of children with SMA also offer hope for improved life expectancy and quality of life.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5q SMA; Dubowitz disease; Kugelberg-Welander disease; Non-5q SMAs; Spinal muscular atrophy; Survival of motor neuron protein; Werdnig-Hoffmann disease

Mesh:

Year:  2015        PMID: 26022173     DOI: 10.1016/j.pcl.2015.03.010

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  32 in total

1.  Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden.

Authors:  Santiago Zuluaga-Sanchez; Megan Teynor; Christopher Knight; Robin Thompson; Thomas Lundqvist; Mats Ekelund; Annabelle Forsmark; Adrian D Vickers; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2019-06       Impact factor: 4.981

Review 2.  A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes.

Authors:  Rebecca R Moultrie; Julia Kish-Doto; Holly Peay; Megan A Lewis
Journal:  J Genet Couns       Date:  2016-04-16       Impact factor: 2.537

3.  Severe ketoacidosis in a patient with spinal muscular atrophy.

Authors:  Bassel Lakkis; Alissar El Chediak; Jana G Hashash; Sahar H Koubar
Journal:  CEN Case Rep       Date:  2018-07-05

Review 4.  Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence.

Authors:  Helgi Thor Hjartarson; Kristofer Nathorst-Böös; Thomas Sejersen
Journal:  Drug Des Devel Ther       Date:  2022-06-16       Impact factor: 4.319

5.  Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.

Authors:  Ali Jalali; Erin Rothwell; Jeffrey R Botkin; Rebecca A Anderson; Russell J Butterfield; Richard E Nelson
Journal:  J Pediatr       Date:  2020-07-11       Impact factor: 4.406

Review 6.  Acute flaccid myelitis: cause, diagnosis, and management.

Authors:  Olwen C Murphy; Kevin Messacar; Leslie Benson; Riley Bove; Jessica L Carpenter; Thomas Crawford; Janet Dean; Roberta DeBiasi; Jay Desai; Matthew J Elrick; Raquel Farias-Moeller; Grace Y Gombolay; Benjamin Greenberg; Matthew Harmelink; Sue Hong; Sarah E Hopkins; Joyce Oleszek; Catherine Otten; Cristina L Sadowsky; Teri L Schreiner; Kiran T Thakur; Keith Van Haren; Carolina M Carballo; Pin Fee Chong; Amary Fall; Vykuntaraju K Gowda; Jelte Helfferich; Ryutaro Kira; Ming Lim; Eduardo L Lopez; Elizabeth M Wells; E Ann Yeh; Carlos A Pardo
Journal:  Lancet       Date:  2020-12-23       Impact factor: 79.321

7.  A novel Xp11.22-22.33 deletion suggesting a possible mechanism of congenital cervical spinal muscular atrophy.

Authors:  Jingwei Liu; Kelai Wang; Baomin Li; Xiaofan Yang
Journal:  Mol Genet Genomic Med       Date:  2021-01-29       Impact factor: 2.183

8.  Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?

Authors:  Alessandro Introna; Giammarco Milella; Eustachio D'Errico; Angela Fraddosio; Gaspare Scaglione; Maria Ucci; Maddalena Ruggieri; Isabella Laura Simone
Journal:  Muscle Nerve       Date:  2021-03-13       Impact factor: 3.217

9.  Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients.

Authors:  Alma Osmanovic; Olivia Schreiber-Katz; Susanne Petri
Journal:  Brain Sci       Date:  2021-03-13

Review 10.  In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.

Authors:  Kristine S Ojala; Emily J Reedich; Christine J DiDonato; Stephen D Meriney
Journal:  Brain Sci       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.